This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Industrial Stocks' Q3 Earnings Due on Oct 23: AIMC, B & ITW
by Zacks Equity Research
The coronavirus outbreak-related issues, higher costs and other headwinds are expected to have affected earnings of the majority of industrial stocks in Q3. Let's see how AIMC, B & ITW are likely to fare.
Is a Surprise Coming for Illinois Tool (ITW) This Earnings Season?
by Zacks Equity Research
Illinois Tool (ITW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
This Week's 5 Red Hot Earnings Charts
by Tracey Ryniec
These five stocks are all soaring and not a single one is a technology company.
Illinois Tool (ITW) to Post Q3 Earnings: Beat in the Cards?
by Zacks Equity Research
Illinois Tool (ITW) Q3 earnings might have gained from strength in consumer packaging businesses, solid product offerings and focus on supply-chain management despite the pandemic-led market downturn.
Illinois Tool Works (ITW) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Illinois Tool Works (ITW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Illinois Tool Shares Gain 19% in 3 Months: What's Driving It?
by Zacks Equity Research
Illinois Tool (ITW), with 19% rise in shares in the past three months, benefits from the reviving U.S. manufacturing activities, solid product offerings, a dividend rate hike and cost-saving measures.
Why Is Illinois Tool Works (ITW) Up 8.1% Since Last Earnings Report?
by Zacks Equity Research
Illinois Tool Works (ITW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Near-Term Outlook Bleak for Industrial Manufacturing Stocks
by Zacks Equity Research
The Manufacturing - General Industrial industry is facing the coronavirus scares, escalating costs and other issues. Higher orders and recovery in manufacturing activities will likely benefit.
Illinois Tool's (ITW) Board Okays 6.5% Hike in Dividend Rate
by Zacks Equity Research
Illinois Tool (ITW), in sync with its shareholder-friendly policies, hikes the quarterly dividend rate by 6.5% or 7 cents.
Illinois Tool (ITW) Q2 Earnings and Sales Beat Estimates
by Zacks Equity Research
Illinois Tool's (ITW) second-quarter results reflect the adverse impacts of the pandemic on sales performance and weak operating margin, partially offset by enterprise initiatives and cost savings.
Illinois Tool Works (ITW) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Illinois Tool Works (ITW) delivered earnings and revenue surprises of 55.71% and 8.66%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stocks' Jul 31 Earnings Roster: CAT, ITW & BERY
by Madhurima Das
With the Industrial Products Sector's second-quarter earnings anticipated to bear the brunt of weak demand amid the COVID-19 pandemic, let's see how some of the stocks are likely to fare in their upcoming releases.
Why Illinois Tool (ITW) Might Surprise This Earnings Season
by Zacks Equity Research
Illinois Tool (ITW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Illinois Tool (ITW) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Illinois Tool (ITW) Q2 results are likely to reflect the pandemic impact, especially on automotive OEM businesses. Diversified businesses, enterprise strategy and cost-cutting might have aided.
What's in Store for Stanley Black & Decker (SWK) Q2 Earnings?
by Zacks Equity Research
Stanley Black & Decker's (SWK) Q2 results are expected to reflect the impacts of the pandemic, forex woes and tariffs. Improved U.S. retail channels and cost-saving measures are likely to have aided.
Xylem (XYL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Xylem's (XYL) Q2 results are expected to reflect the adverse impacts of the pandemic on its operations. Solid contract wins, product offerings and cost-management are likely to have been tailwinds.
Can Illinois Tool Works (ITW) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Illinois Tool Works (ITW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Illinois Tool Works (ITW) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Illinois Tool Works (ITW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Industrial Stocks Poised for an Earnings Beat in Q2
by Payal Jalan
Industrial product stocks are expected to reflect gains from the pandemic-led product demand, spur in e-commerce and cost-saving measures. We present five stocks poised for an earnings beat in Q2.
FERGY vs. ITW: Which Stock Is the Better Value Option?
by Zacks Equity Research
FERGY vs. ITW: Which Stock Is the Better Value Option?
Middleby's Liquidity & Cost-Saving Moves to Aid Amid Pandemic
by Zacks Equity Research
Middleby's (MIDD) segments face risks from the pandemic-related uncertainties and high leverage position. However, healthy liquidity, buyouts and cost-saving measures are likely to aid.
Why Is Illinois Tool Works (ITW) Up 12.4% Since Last Earnings Report?
by Zacks Equity Research
Illinois Tool Works (ITW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Illinois Tool's (ITW) Prospects Bleak on Pandemic Qualms
by Zacks Equity Research
Illinois Tool (ITW) suffers from the adverse impacts of the pandemic and expects sales to fall 30-40% in the second quarter. Forex woes and high debts are other concerns.
Middleby (MIDD) Declines 38% YTD: What's Hurting the Stock?
by Zacks Equity Research
Middleby (MIDD), with a 38% decline in shares so far in 2020, faces the adverse impacts of the pandemic, high debts and forex woes. However, cost-reduction actions might aid.
Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?
by Zacks Equity Research
Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns. However, cost-reduction actions might aid.